Works matching IS 09024441 AND DT 2020 AND VI 105 AND IP 1
Results: 12
Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 94, doi. 10.1111/ejh.13414
- By:
- Publication type:
- Article
Mixed phenotype acute leukemia: Biological profile, clinical characteristic and treatment outcomes: Report of the population‐based study.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 85, doi. 10.1111/ejh.13413
- By:
- Publication type:
- Article
Cellular immune response to acute exercise: Comparison of endurance and resistance exercise.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 75, doi. 10.1111/ejh.13412
- By:
- Publication type:
- Article
A randomized, double‐blind, single‐dose, three‐arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris<sup>®</sup>) in healthy male subjects.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 66, doi. 10.1111/ejh.13411
- By:
- Publication type:
- Article
The changing epidemiology of the ageing thalassaemia populations: A position statement of the Thalassaemia International Federation.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 16, doi. 10.1111/ejh.13410
- By:
- Publication type:
- Article
The multi‐tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: Real‐world data.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 3, doi. 10.1111/ejh.13408
- By:
- Publication type:
- Article
Network meta‐analysis of first‐line treatments in transplant‐ineligible multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 56, doi. 10.1111/ejh.13407
- By:
- Publication type:
- Article
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 47, doi. 10.1111/ejh.13406
- By:
- Publication type:
- Article
c‐MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide‐dexamethasone in myeloma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 35, doi. 10.1111/ejh.13405
- By:
- Publication type:
- Article
Bortezomib washout duration prior to stem cell mobilization in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 30, doi. 10.1111/ejh.13404
- By:
- Publication type:
- Article
Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 24, doi. 10.1111/ejh.13403
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 1, doi. 10.1111/ejh.13257
- Publication type:
- Article